Literature DB >> 8329510

Consequences of intravascular catheter sepsis.

P M Arnow1, E M Quimosing, M Beach.   

Abstract

Intravascular (IV) catheter sepsis is a widely recognized complication of IV therapy or monitoring, but little emphasis has been placed on the morbidity and cost associated with this infection. To assess the consequences of IV catheter sepsis, we examined the medical records of 94 patients with 102 episodes of IV catheter sepsis due to percutaneously inserted catheters. Major complications occurred in 33 (32%) of the episodes and included septic shock (12 episodes), sustained sepsis (12), suppurative thrombophlebitis (7), metastatic infection (5), endocarditis (2), and arteritis (2). One patient died due to sepsis, and hospital stay was clearly prolonged in 15 episodes. The risk of major complications was highest in episodes of IV catheter sepsis caused by Candida, Pseudomonas aeruginosa, Staphylococcus aureus, or multiple pathogens, and the most severe complications were usually caused by S. aureus. The hospital cost of IV catheter sepsis was assessed by reviewing medical and billing records to identify extra medical care and then multiplying charges for that care by the appropriate cost-to-charge ratio. The average cost per episode, adjusted to 1991 dollars, was $3,707 for all episodes and $6,064 for episodes caused by S. aureus. The morbidity and cost associated with IV catheter sepsis warrant substantial efforts to minimize the incidence of this complication and especially to prevent cases due to S. aureus.

Entities:  

Mesh:

Year:  1993        PMID: 8329510     DOI: 10.1093/clind/16.6.778

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  34 in total

Review 1.  Diagnosis of central venous catheter related sepsis--a critical look inside.

Authors:  B M Dobbins; P Kite; M H Wilcox
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

2.  Economic aspects of innovations in medical technology.

Authors:  P Oberender; S Ruckdäschel; S Lugauer; J P Guggenbichler
Journal:  Infection       Date:  1999       Impact factor: 3.553

3.  Standardizing the definition and measurement of catheter-related infection in home care: a proposed outcome measurement system.

Authors:  D L Zimay
Journal:  J Med Syst       Date:  1999-06       Impact factor: 4.460

4.  Adhesive tape and intravascular-catheter-associated infections.

Authors:  D A Redelmeier; N J Livesley
Journal:  J Gen Intern Med       Date:  1999-06       Impact factor: 5.128

Review 5.  General medical care on the neuromedical intensive care unit.

Authors:  Robin S Howard; Jeremy Radcliffe; Nicholas P Hirsch
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

6.  Intravascular catheter related infections in children admitted on the paediatric wards of Mulago Hospital, Uganda.

Authors:  Patricia Nahirya; Justus Byarugaba; Sarah Kiguli; Deogratias Kaddu-Mulindwa
Journal:  Afr Health Sci       Date:  2008-12       Impact factor: 0.927

Review 7.  Infections associated with medical devices: pathogenesis, management and prophylaxis.

Authors:  Christof von Eiff; Bernd Jansen; Wolfgang Kohnen; Karsten Becker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

8.  NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.

Authors:  Clint S Schmidt; C Jo White; Ashraf S Ibrahim; Scott G Filler; Yue Fu; Michael R Yeaman; John E Edwards; John P Hennessey
Journal:  Vaccine       Date:  2012-10-22       Impact factor: 3.641

9.  Combined skin disinfection with chlorhexidine/propanol and aqueous povidone-iodine reduces bacterial colonisation of central venous catheters.

Authors:  Julia Langgartner; Hans-Jörg Linde; Norbert Lehn; Michael Reng; Jürgen Schölmerich; Thomas Glück
Journal:  Intensive Care Med       Date:  2004-04-15       Impact factor: 17.440

10.  Vancomycin flush as antibiotic prophylaxis for early catheter-related infections: a cost-effectiveness analysis.

Authors:  Nicolas Penel; Yazdan Yazdanpanah
Journal:  Support Care Cancer       Date:  2008-07-29       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.